CBO: Biogenerics Would Save Federal Government $6.6 Billion Over... ( Creation of Clear Regulatory Path...)

CBO: Biogenerics Would Save Federal Government $6.6 Billion Over Ten Years

Date:6/25/2008

Creation of Clear Regulatory Pathway Would Also Lower Total Expenditures for Biologics by $25 Billion Over Ten Years

WASHINGTON, June 25 /PRNewswire-USNewswire/ -- The Congressional Budget Office (CBO) today released a cost analysis finding that the creation of an abbreviated pathway for follow-on biologics -- or biogenerics -- would save the federal government $6.6 billion over ten years and lower total expenditures for biologics by $25 billion over the same time period.

"For a quarter century, generic versions of chemical drugs have saved consumers and payors billions of dollars. Now, CBO has confirmed that giving FDA additional authority to approve generic versions of biologics will save billions more," said PCMA President and CEO Mark Merritt. "Even greater savings would be available if Congress simply applied to biologics the Hatch-Waxman standards that are currently used to approve generics for chemical compounds. It would be helpful if some provisions in the bill -- such as 'evergreening' -- which unnecessarily delay the entry of biogenerics were reconsidered. CBO acknowledges that the 'evergreening' issue will present significant problems beyond the ten-year scoring window."

CBO estimates that:

-- Enacting S. 1695 would reduce total expenditures on biologics in the

United States Hidden List by $25 billion over the 2009-2018

period.

-- Enacting the bill would reduce budget deficits (or increase surpluses)

by a total of $6.6 billion over the 2009-2018 period.

Unlike conventional drugs, there is no clear regulatory process where biogenerics can be approved by the FDA. PCMA was joined by a number of influential consumer, employer, and insurer groups who endorsed the "Access to Life Saving Medicine Act of 2007," bipartisan legislation that seeks to create a clear regulatory pathway for biogenerics.

PCMA is the national association representing Americ
'/>"/>

SOURCE Pharmaceutical Care Management Association
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related biology technology :

1. Amgen and Genentech Brace Themselves for Heavy Pressure From Biogenerics Manufacturers
2. Biogenerics Will Save Billions, Says Hospira CEO
3. Entry of Biogenerics and Decreasing Use of Amgens Epogen and Johnson & Johnsons Procrit Will Cause a $2.8 Billion Decline in the Drug Market for Chemotherapy-Induced Anemia by 2016
4. Coalition for a Competitive Pharmaceutical Market Launches New Print Ad Campaign Highlighting Need for Meaningful Biogenerics Legislation
5. Op-Ed: The NBAF Would Build on Kansas Existing Strengths in Bioscience
6. Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision
7. Federal Trade Commission Clears Kyphons Acquisition of Non-Vertebroplasty Spine-Related Assets of Disc-O-Tech
8. NIH Announces Advanced Cell Technologys Single Cell Embryo Biopsy Technique as a Means to Derive Embryonic Stem Cells to be Considered for Federal Funding
9. Zimmer Announces Settlement of Federal Investigation
10. DelSite Nasal Powder Technology Could Reduce Recently Reported Waste in Federal Vaccine Program
11. Federally-Funded Study Shows More Women Can Avoid Hysterectomy for Common Problem

Post Your Comments:

(Date:5/15/2012)... have taken a step toward overcoming a ... that could bring optical advances including ultrapowerful ... researchers have shown how to create the ... previously required, said Alexandra Boltasseva, a Purdue ... engineering. , Using the metals is impractical ...

(Date:5/15/2012)... OrbusNeich today announced that 12-month follow-up data from ... involving the use of the company,s Combo Dual Therapy ... ® paclitaxel-eluting stent. The data were presented by ... Lukaskrankenhaus in Neuss, Germany, at EuroPCR 2012. ... driven target lesion failure (TLF) rate was 8.9% for ...

(Date:5/15/2012)... -- Cardium Therapeutics (NYSE Amex: CXM ... first quarter ended March 31, 2012, and other ... In addition to the announcement ... its goals for 2012, which were outlined in ... advance commercialization of its new Excellagen® advanced, physician-use ...

(Date:5/15/2012)... Butamax™ Advanced Biofuels, LLC announced ... Trademark Office (USPTO) has granted Butamax Patent ... highly efficient engineered pathway for producing isobutanol ... novel microorganisms have been designed using advanced ... (Logo: http://photos.prnewswire.com/prnh/20120209/MM50763LOGO ) ...

[0] New 'metamaterial' practical for optical advances [0] OrbusNeich's Combo Dual Therapy Stent™ Demonstrates Favorable Clinical and Safety Outcomes at 12-Month Follow-Up [0] Cardium Presents First Quarter 2012 Financial Results and Recent Developments [0] Butamax Granted Core Patent for Making Biobutanol and Distillers Grains; Offers Producers Efficient, Low-Cost Production of Biobutanol

... an economic environment where many healthcare providers are ... patients are thriving with help from InstaMed. ... and platform, Prime Health Network has increased patient ... while also improving the patient experience at each ...

... biotechnology company delivering breakthrough therapies in central nervous system ... participating at two upcoming healthcare investor conferences. Dr. Steve ... 2nd Annual BIO Venture Conference on April 1 at ... Boston, MA. On April 9 at 11:30 a.m. PDT, ...

... Shire plc (LSE: SHP, NASDAQ:, SHPGY ), the ... Accounts in respect of the year ended December 31, ... announced unaudited full,year 2008 results, prepared in accordance with ... announcement on February 19,2009. , ...

Prime Health Network and Its Patients Thrive in Tough Economic Times on the InstaMed Network Accera, Inc. to Present at Upcoming Investor Conferences Publication of Shire plc's Annual Report 2008

(Date:5/21/2012)... team of scientists from the National University of Singapore,s ... discovered how a drug-led compound a compound that ... can deprive cancer cells of energy and stop them ... named BPTES. , This is the first time ... drug-lead compound suppresses tumour formation. , Building on ...

(Date:5/21/2012)... , , , , , ... , , , , , ... thanks to breakthrough research by CSIRO researchers who have supercharged safflower to produce increased amounts... , , ... , , , , , ... , , , , , , , , ...

(Date:5/20/2012)... melody, the male songbird uses a trial-and-error process to mimic ... over again, hundreds of times a day, making subtle changes ... finch, this rigorous training process begins around the age of ... he becomes sexually mature and ready to use his song ... brain must receive and process large quantities of information about ...

Breaking Biology News(10 mins):Novel discovery by NUS scientists paves the way for more effective treatment of cancers 2 Supercharged safflower 2 Supercharged safflower 3 Supercharged safflower 4 Songbirds' learning hub in brain offers insight into motor control 2 Songbirds' learning hub in brain offers insight into motor control 3 Luminex Corporation Reports Second Quarter 2011 Results 19401 1 Luminex Corporation Reports Second Quarter 2011 Results 19401 2 Luminex Corporation Reports Second Quarter 2011 Results 19401 3 Luminex Corporation Reports Second Quarter 2011 Results 19401 4 Luminex Corporation Reports Second Quarter 2011 Results 19401 5 Luminex Corporation Reports Second Quarter 2011 Results 19401 6 Luminex Corporation Reports Second Quarter 2011 Results 19401 7 Luminex Corporation Reports Second Quarter 2011 Results 19401 8 Luminex Corporation Reports Second Quarter 2011 Results 19401 9 NeurogesX Inc Secures 2420 Million Debt Facility 19398 1 NeurogesX Inc Secures 2420 Million Debt Facility 19398 2 NeurogesX Inc Secures 2420 Million Debt Facility 19398 3 NeurogesX Inc Secures 2420 Million Debt Facility 19398 4 As Heart Failure Worsens Word Recall May Suffer Too 84250 1

[0] Novel discovery by NUS scientists paves the way for more effective treatment of cancers [0] Supercharged safflower [0] Songbirds' learning hub in brain offers insight into motor control

... flavanols, the unique compounds found naturally in cocoa, may ... research published in the Neuropsychiatric Disease and Treatment journal. ... flow could impact cognitive behavior, offering future potential for ... a scientific study of healthy, older adults ages 59 ...

... entrepreneurial geneticist Craig Venter sailed around the world on ... ambitious project to use genetics to understand invisible ecological ... jumble of mystery DNA fragments belonging to thousands of ... University of Washington scientist has studied lake mud, which ...

... the sweeping destruction of the 1918 flu pandemic, researchers at ... to the virus from elderly survivors of the original ... long-lasting immunity to such viruses, these antibodies could be effective ... the 1918 flu breaks out in the future. , ...

Other Biology News:Researchers link cocoa flavanols to improved brain blood flow 2 Researchers link cocoa flavanols to improved brain blood flow 3 Cataloguing invisible life: Microbe genome emerges from lake sediment 2 Cataloguing invisible life: Microbe genome emerges from lake sediment 3 1918 flu antibodies resurrected from elderly survivors 2

Researchers link cocoa flavanols to improved brain blood flow Cataloguing invisible life: Microbe genome emerges from lake sediment 1918 flu antibodies resurrected from elderly survivors

... Agencourt offers single pass sequencing ... service is fueled by our high ... 20 million Phred20 bases per day. ... single pass sequencing customers are rapid ...

GLP-compliant, CLIA-certified DNA sequencing service. ASQ and SQA certified quality assurance staff. Auditors welcome....

...

... calibration, and validation (MCV) plate ... plate used for hands-free startup, ... using the Bio-Plex suspension array ... for use with Bio-Plex Manager ...

Biology Products:

Single Pass DNA Sequencing from Agencourt Bioscience FDA-Submission Quality DNA Sequencing from Seqwright Cytomics FC 500 Series Flow Cytometry Systems from Beckman Coulter Bio-Plex MCV Plate III from Bio-Rad

CBO: Biogenerics Would Save Federal Government $6.6 Billion Over...( Creation of Clear Regulatory Path...)